[Treatment of cardiogenic shock in acute coronary syndrome. Do logistics follow logic?].

A. Mysiak,M. Kobusiak-Prokopowicz

2007-07-01

Kardiologia Polska

Abstract:

What problem does this paper attempt to address?

Telomerase Activity of Hiv-1-Specific Cd8(+) T Cells: Constitutive Up-Regulation in Controllers and Selective Increase by Blockade of Pd Ligand 1 in Progressors

Mathias Lichterfeld,Danlei Mou,Thai Duong Hong Cung,Katie L. Williams,Michael T. Waring,Jinghe Huang,Florencia Pereyra,Alicja Trocha,Gordon J. Freeman,Eric S. Rosenberg,Bruce D. Walker,Xu G. Yu

DOI: https://doi.org/10.1182/blood-2008-01-135442

IF: 20.3

2008-01-01

Blood

Abstract:Exhaustion of virus-specific T cells may play an important role in the pathophysiology of chronic viral infections. Here, we analyzed telomere length and telomerase activity in HIV-1-specific CD8+ T cells from progressors or controllers to determine underlying molecular pathways of T-cell exhaustion and senescence. Telomere lengths of HIV-1-specific CD8+ T cells from progressors were significantly shorter compared with autologous cytomegalovirus (CMV)/Epstein-Barr virus (EBV)-specific CD8+ T cells or bulk CD8+ T cells, while telomere lengths from controllers significantly exceeded those of autologous bulk CD8+ T cells and reached a similar level as HIV-1-specific CD8+ T cells collected during primary HIV-1 infection. Telomere length stabilization in controllers corresponded to high levels of constitutive telomerase activity, which was associated with preservation of cytotoxic and proliferative properties. Conversely, limited constitutive telomerase activity was observed in HIV-1-specific CD8+ T cells from progressors, although an increase in both telomere length and telomerase activity was achieved in antigenic-peptide-stimulated cells from progressors after blocking the PD-1/PD ligand 1 (PD-L1) pathway. Collectively, these data suggest a causal role of telomere shortening for the functional deficiencies of HIV-1-specific CD8+ T cells in chronic progressive infection, while high constitutive telomerase activities appears to contribute to maintenance of polyfunctional HIV-1-specific CD8+ T cells from HIV-1 controllers.
Altered differentiation is central to HIV-specific CD4+ T cell dysfunction in progressive disease

Antigoni Morou,Elsa Brunet-Ratnasingham,Mathieu Dubé,Roxanne Charlebois,Eloi Mercier,Sam Darko,Nathalie Brassard,Krystelle Nganou-Makamdop,Sahaana Arumugam,Gabrielle Gendron-Lepage,Lifei Yang,Julia Niessl,Amy E. Baxter,James M. Billingsley,Premeela A. Rajakumar,François Lefebvre,R. Paul Johnson,Cécile Tremblay,Jean-Pierre Routy,Richard T. Wyatt,Andrés Finzi,Daniel C. Douek,Daniel E. Kaufmann

DOI: https://doi.org/10.1038/s41590-019-0418-x

IF: 30.5

2019-07-15

Nature Immunology

Abstract:Dysfunction of virus-specific CD4+ T cells in chronic human infections is poorly understood. We performed genome-wide transcriptional analyses and functional assays of CD4+ T cells specific for human immunodeficiency virus (HIV) from HIV-infected people before and after initiation of antiretroviral therapy (ART). A follicular helper T cell (TFH cell)-like profile characterized HIV-specific CD4+ T cells in viremic infection. HIV-specific CD4+ T cells from people spontaneously controlling the virus (elite controllers) robustly expressed genes associated with the TH1, TH17 and TH22 subsets of helper T cells. Viral suppression by ART resulted in a distinct transcriptional landscape, with a reduction in the expression of genes associated with TFH cells, but persistently low expression of genes associated with TH1, TH17 and TH22 cells compared to the elite controller profile. Thus, altered differentiation is central to the impairment of HIV-specific CD4+ T cells and involves both gain of function and loss of function.

immunology
Persistent T Cell Repertoire Perturbation and T Cell Activation in HIV After Long Term Treatment

Carolin T Turner,James Brown,Emily Shaw,Imran Uddin,Evdokia Tsaliki,Jennifer K Roe,Gabriele Pollara,Yuxin Sun,James M Heather,Marc Lipman,Benny Chain,Mahdad Noursadeghi

DOI: https://doi.org/10.3389/fimmu.2021.634489

2021-02-25

Abstract:Objective: In people living with HIV (PLHIV), we sought to test the hypothesis that long term anti-retroviral therapy restores the normal T cell repertoire, and investigate the functional relationship of residual repertoire abnormalities to persistent immune system dysregulation. Methods: We conducted a case-control study in PLHIV and HIV-negative volunteers, of circulating T cell receptor repertoires and whole blood transcriptomes by RNA sequencing, complemented by metadata from routinely collected health care records. Results: T cell receptor sequencing revealed persistent abnormalities in the clonal T cell repertoire of PLHIV, characterized by reduced repertoire diversity and oligoclonal T cell expansion correlated with elevated CD8 T cell counts. We found no evidence that these expansions were driven by cytomegalovirus or another common antigen. Increased frequency of long CDR3 sequences and reduced frequency of public sequences among the expanded clones implicated abnormal thymic selection as a contributing factor. These abnormalities in the repertoire correlated with systems level evidence of persistent T cell activation in genome-wide blood transcriptomes. Conclusions: The diversity of T cell receptor repertoires in PLHIV on long term anti-retroviral therapy remains significantly depleted, and skewed by idiosyncratic clones, partly attributable to altered thymic output and associated with T cell mediated chronic immune activation. Further investigation of thymic function and the antigenic drivers of T cell clonal selection in PLHIV are critical to efforts to fully re-establish normal immune function.
[The effect of local injection of interferon against human malignant glioma transplanted into nude mice and the mechanism of its effect].

T. Hori,Y. Inoue,Y. Hokama,F. Yamamoto,M. Iwanaga,T. Watanabe

1989-09-01

Abstract:In order to clarify the mechanism of action of recombinant human leucocyte interferon, the effect of local injection of it to the human malignant gliomas (one oligodendroglioma, the other glioblastoma) transplanted into nude mice were evaluated. The volume of the tumors were calculated as 1/2 (short diameter [cm])2 x (long diameter[cm]). And the ratio of tumor volume (T)/original size (C) were calculated in terms of experimental day. Among the groups of control (vehicle of IFN injected), 1 million units of IFN locally injected group, 3 million units injected group, and 9 million units injected group, the effects of the treatment were statistically evaluated in terms of T/C. At the end of the experiment, each animal was injected 4 mg of BrdU intraperitoneally, and the labeling indices of the tumor tissue were measured and compared among the groups above mentioned. Local injection of IFN to the tumor was effective even at the dose of 1 million units every other day for 16 days for glioblastoma and 50 days for oligodendroglioma. The labeling index of the treated groups was significantly reduced when compared to that of control group in both tumors. And the experiment was performed to evaluate the variation of NK activity and ADCC activity of mouse spleen cells among the experimental groups. For the oligodendroglioma, NK activities were significantly increased in the 9 million units of IFN injected group when compared to those of control group. For glioblastoma, there was no definite variation of NK and ADCC activities among the groups.(ABSTRACT TRUNCATED AT 250 WORDS)
Seeking "protective" and "harmful" immune genes during chronic HIV-1 infection by transcriptome analysis

Zhu Lingyan,Qiu Chao,Qiu Chenli,Wang Ying,Dong Yuan,Zhang Linxia,Fu Weihui,Wei Jun,Zhang Xiaoyan,Xu Jianqing

DOI: https://doi.org/10.1097/jbr.0000000000000015

2018-01-01

Journal of Bio-X Research

Abstract:Human immunodeficiency virus (HIV)-infected individuals exhibit remarkable transcriptomic variation. Transcriptome analyses of antiretroviral therapy (ART)-free chronically infected HIV-1 patients with different clinical outcomes are likely to aid the development of vaccine and immune therapies. Here, we performed microarray analyses on whole-blood derived RNA from 89 ART-free HIV-1-infected individuals from 2 cohorts. The differentially expressed genes were analyzed between long-term non-progressors, viremic non-progressors and typical progressors, and between elite controllers and non-elite controllers among the long-term non-progressors. Several genes related to T-cell growth, proliferation and differentiation and antiapoptosis were upregulated, whereas interferon-stimulated genes and inflammatory genes were significantly downregulated in long-term non-progressors and viremic non-progressors. The observations above were further confirmed in the set of 261 genes that correlated with disease progression during a 5-year follow-up, which included 51 genes significantly associated with slower disease progression, and 210 genes associated with aggressive disease progression. Overall, our data suggest that it is vital to maintain the homeostasis of the immune system when mounting antiviral immune responses. Immune therapeutics able to reconstruct immune homeostasis are likely to be required for immune reconstitution in the context of ART, such as the administration of interleukin-7, healthy allogenic CD4 + T cells (providing CD4 + T-cell growth factors), or Tregs.
Metabolic and mitochondrial dysregulation in CD4+ T cells from HIV-positive women on combination anti-retroviral therapy

Matrona Akiso,Magdalene Ameka,Kewreshini Naidoo,Robert Langat,Janet Kombo,Delories Sikuku,Thumbi Ndung'u,Marcus Altfeld,Omu Anzala,Marianne Mureithi

DOI: https://doi.org/10.1371/journal.pone.0286436

IF: 3.7

2023-10-10

PLoS ONE

Abstract:Background: For optimal functionality, immune cells require a robust and adaptable metabolic program that is fueled by dynamic mitochondrial activity. In this study, we investigate the metabolic alterations occurring in immune cells during HIV infection and antiretroviral therapy by analyzing the uptake of metabolic substrates and mitochondrial phenotypes. By delineating changes in immune cell metabolic programming during HIV, we may identify novel potential therapeutic targets to improve anti-viral immune responses. Methods: After consent and voluntary participation was confirmed, whole blood was drawn from HIV uninfected women and women with chronic HIV infection on long-term combination antiretroviral therapy (HIV/cART). Peripheral blood mononuclear cells-derived immune cells were directly incubated with different fluorescently tagged metabolites and markers of mitochondrial activity: FITC-2-NBDG (2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) amino]-2-deoxy-D-glucose), FITC-BODIPY (4,4-Difluoro-5,7-Dimethyl-4-Bora-3a,4a-Diaza-s-Indacene-3-Hexadecanoic Acid), FITC-MitoTracker Green and APC-MitoTracker Deep Red. The uptake of glucose and fats and the mitochondrial mass and potential were measured using flow cytometry. All values are reported quantitatively as geometric means of fluorescence intensity. Results: During chronic HIV infection, cellular uptake of glucose increases in HIV+ dendritic cells in particular. CD4+ T cells had the lowest uptake of glucose and fats compared to all other cells regardless of HIV status, while CD8+ T cells took up more fatty acids. Interestingly, despite the lower utilization of glucose and fats in CD4+ T cells, mitochondrial mass increased in HIV+ CD4+ T cells compared to HIV negative CD4+ T-cells. HIV+ CD4+ T cells also had the highest mitochondrial potential. Conclusions: Significant disparities in the utilization of substrates by leukocytes during chronic HIV/cART exist. Innate immune cells increased utilization of sugars and fats while adaptive immune cells displayed lower glucose and fat utilization despite having a higher mitochondrial activity. Our findings suggest that cART treated HIV-infected CD4+ T cells be dysfunctional or may prefer alternative fuel sources not included in these studies. This underscores the importance of understanding the metabolic effects of HIV treatment on immune function.
Genome-wide analysis of primary CD4+ and CD8+ T cell transcriptomes shows evidence for a network of enriched pathways associated with HIV disease

Jing Qin Wu,Dominic E Dwyer,Wayne B Dyer,Yee Hwa Yang,Bin Wang,Nitin K Saksena

DOI: https://doi.org/10.1186/1742-4690-8-18

2011-03-16

Retrovirology

Abstract:Background: HIV preferentially infects CD4+ T cells, and the functional impairment and numerical decline of CD4+ and CD8+ T cells characterize HIV disease. The numerical decline of CD4+ and CD8+ T cells affects the optimal ratio between the two cell types necessary for immune regulation. Therefore, this work aimed to define the genomic basis of HIV interactions with the cellular transcriptome of both CD4+ and CD8+ T cells. Results: Genome-wide transcriptomes of primary CD4+ and CD8+ T cells from HIV+ patients were analyzed at different stages of HIV disease using Illumina microarray. For each cell subset, pairwise comparisons were performed and differentially expressed (DE) genes were identified (fold change >2 and B-statistic >0) followed by quantitative PCR validation. Gene ontology (GO) analysis of DE genes revealed enriched categories of complement activation, actin filament, proteasome core and proton-transporting ATPase complex. By gene set enrichment analysis (GSEA), a network of enriched pathways functionally connected by mitochondria was identified in both T cell subsets as a transcriptional signature of HIV disease progression. These pathways ranged from metabolism and energy production (TCA cycle and OXPHOS) to mitochondria meditated cell apoptosis and cell cycle dysregulation. The most unique and significant feature of our work was that the non-progressing status in HIV+ long-term non-progressors was associated with MAPK, WNT, and AKT pathways contributing to cell survival and anti-viral responses. Conclusions: These data offer new comparative insights into HIV disease progression from the aspect of HIV-host interactions at the transcriptomic level, which will facilitate the understanding of the genetic basis of transcriptomic interaction of HIV in vivo and how HIV subverts the human gene machinery at the individual cell type level.
Reversible Reprogramming of Circulating Memory T Follicular Helper Cell Function during Chronic HIV Infection

Rafael Cubas,Julien van Grevenynghe,Saintedym Wills,Lela Kardava,Brian H Santich,Clarisa M Buckner,Roshell Muir,Virginie Tardif,Carmen Nichols,Francesco Procopio,Zhong He,Talibah Metcalf,Khader Ghneim,Michela Locci,Petronella Ancuta,Jean-Pierre Routy,Lydie Trautmann,Yuxing Li,Adrian B McDermott,Rick A Koup,Constantinos Petrovas,Steven A Migueles,Mark Connors,Georgia D Tomaras,Susan Moir,Shane Crotty,Elias K Haddad,Brian H. Santich,Clarisa M. Buckner,Adrian B. McDermott,Rick A. Koup,Steven A. Migueles,Georgia D. Tomaras,Elias K. Haddad

DOI: https://doi.org/10.4049/jimmunol.1501524

2015-11-06

The Journal of Immunology

Abstract:Despite the overwhelming benefits of antiretroviral therapy (ART) in curtailing viral load in HIV-infected individuals, ART does not fully restore cellular and humoral immunity. HIV-infected individuals under ART show reduced responses to vaccination and infections and are unable to mount an effective antiviral immune response upon ART cessation. Many factors contribute to these defects, including persistent inflammation, especially in lymphoid tissues, where T follicular helper (Tfh) cells instruct and help B cells launch an effective humoral immune response. In this study we investigated the phenotype and function of circulating memory Tfh cells as a surrogate of Tfh cells in lymph nodes and found significant impairment of this cell population in chronically HIV-infected individuals, leading to reduced B cell responses. We further show that these aberrant memory Tfh cells exhibit an IL-2-responsive gene signature and are more polarized toward a Th1 phenotype. Treatment of functional memory Tfh cells with IL-2 was able to recapitulate the detrimental reprogramming. Importantly, this defect was reversible, as interfering with the IL-2 signaling pathway helped reverse the abnormal differentiation and improved Ab responses. Thus, reversible reprogramming of memory Tfh cells in HIV-infected individuals could be used to enhance Ab responses. Altered microenvironmental conditions in lymphoid tissues leading to altered Tfh cell differentiation could provide one explanation for the poor responsiveness of HIV-infected individuals to new Ags. This explanation has important implications for the development of therapeutic interventions to enhance HIV- and vaccine-mediated Ab responses in patients under ART.

immunology
Human heterophile antibodies recognizing epitopes present on insect glycolipids.

G. Nores,R. Dennis,F. Helling,H. Wiegandt

DOI: https://doi.org/10.1093/OXFORDJOURNALS.JBCHEM.A123526

1991-07-01

Abstract:As a consequence of detecting an IgM M-protein (naturally occurring diseased-state monoclonal antibody) immunoreactive to insect acidic glycolipids in a patient with demyelinating peripheral neuropathy, normal human sera were examined for the occurrence of heterophile antibodies directed against carbohydrate epitopes present on glycosphingolipids of Calliphora vicina (Insecta: Diptera). The insect glycolipids can be separated into neutral, zwitterionic, and acidic types, according to whether the oligosaccharide chains consist of neutral monosaccharides only, or carry an additional phospho-ethanolamine side chain and/or a beta-glucuronic acid residue, respectively. Natural antibody activity to these three classes of insect glycosphingolipids was detected in all normal human sera examined. The antibody activities were separated by sequential chromatography on affinity columns of octyl-Sepharose 4B-bound neutral and zwitterionic glycolipids into three populations with differing epitope-type specificities. As expected for heterophile antibodies, they are mainly of the IgM class. Population I recognized epitopes present on the three types of insect glycolipids, i.e., the neutral oligosaccharide chain backbone, the main determinant of which contains a terminal N-acetylhexosamine. Immunoreactivity is separable into at least four subpopulations of differing carbohydrate epitope specificity. Population II recognized epitopes containing phosphoethanolamine in zwitterionic and some acidic insect glycolipids. There are two subpopulations, the majority of which require the free amino group of phosphoethanolamine for immunoreactivity. Population III antibodies showed immunoreactivity to terminal beta-glucuronic acid-containing epitopes present only on acidic insect glycolipids.
Distinct Mitochondrial Disturbance in CD4+T and CD8+T Cells From HIV-Infected Patients

Fengting Yu,Yu Hao,Hongxin Zhao,Jiang Xiao,Ning Han,Yu Zhang,Guorui Dai,Xuejing Chong,Hui Zeng,Fujie Zhang

DOI: https://doi.org/10.1097/QAI.0000000000001175

2017-02-01

Abstract:Background: Mitochondrial dysfunction has frequently been found in HIV-infected patients regardless of whether they received antiretroviral therapy (ART). Accumulating evidence suggests that HIV-infected patients exhibit marked changes in mitochondrial membrane potential (MMP), reactive oxygen species (ROS) accumulation, adenosine triphosphate generation, mitochondrial mass (MM), mitochondrial DNA, etc. However, mitochondrial toxicity in CD4T and CD8T cells caused by different levels of HIV progression and ART is poorly understood. Methods: Blood samples were obtained from 97 ART-naïve HIV-infected patients with different CD4T cell counts, 97 nucleoside-reverse transcriptase inhibitors-exposed HIV-infected patients, and 25 HIV-negative subjects. MMP, ROS, and MM in CD4T and CD8T cells were assessed by flow cytometry. Results: In healthy subjects, the levels of MMP and MM in CD4T cells were higher than those in CD8T cells. HIV infection led to an increase in MM in CD4T and CD8T cells, but mainly influenced MMP in CD8T cells and ROS accumulation in CD4T cells. MM in CD4T and CD8T cells gradually increased after the loss of CD4T cells. Although the dynamic changes in MMP in CD4T cells were different from those in CD8T cells during highly active ART, MM in both CD4T and CD8T cells was significantly decreased after 2 years of therapy, but increased again after 3 years. Conclusions: HIV infection and antiretroviral therapy both led to mitochondrial disturbances in CD4T cells and CD8T cells; however, the abnormal changes in mitochondrial parameters in CD4+T cells were different from those in CD8T cells caused by HIV infection and antiretroviral therapy.
Metabolic reprogramming of immune cells in HIV infection and treatment

Di Wu,Phoebe Xu

DOI: https://doi.org/10.1101/2024.09.26.615098

2024-09-29

Abstract:BACKGROUND: Immune cells undergo metabolic reprogramming, altering their energy production in response to HIV infection. During acute HIV infection, CD4+ T cells increase glycolysis to fuel viral replication and defense, but prolonged activation leads to immune exhaustion, with reduced T cell function and impaired pathogen elimination, contributing to AIDS progression. However, the details Metabolic dynamics of Immune Cells during HIV Infection (UT) and after receiving antiretroviral therapy (ART) remains unknown. Communication between Immune cells will be modified to response HIV infection, which can be mediated by metabolites. In this study, we deciphered Metabolic pathway dynamics of all Immune Cells by comparing UT and ART with seronegative controls (SN). Additionally, we investigate alteration of metabolite-mediated cell-cell communications in HIV Infection. METHODS: Single cell RNA sequencing (scRNA-seq) data of PBMC from SN, UT and ART were analyzed with KEGG Metabolic pathways by irGSEA and algorithm MEBOCOST to study cell-cell communications mediated by metabolites from sender cells and sensor proteins on receiver cells. RESULTS: lots of differentially expressed Metabolic Pathways were identified for immune cells, including Energy Production and Utilization, Lipid Metabolism, Amino Acid Metabolism, Glycosylation and Glycan Biosynthesis and Oxidative Stress and Antioxidant Defense. CONCLUSIONS: The analysis highlights the intricate metabolic interplay between monocytes and other immune cells, reflecting their central role in orchestrating immune responses through metabolite exchange. These insights may open avenues for therapeutic interventions, targeting metabolic pathways to enhance immune function or inhibit pathogen survival.

Immunology
Landscape of T Cells Transcriptional and Metabolic Modules During HIV Infection Based on Weighted Gene Co-expression Network Analysis

Jianting Xu,Jiahui Pan,Xin Liu,Nan Zhang,Xinyue Zhang,Guoqing Wang,Wenyan Zhang

DOI: https://doi.org/10.3389/fgene.2021.756471

IF: 3.7

2021-09-16

Frontiers in Genetics

Abstract:Human immunodeficiency virus (HIV) causes acquired immunodeficiency syndrome (AIDS). HIV infection affects the functions and metabolism of T cells, which may determine the fate of patients; however, the specific pathways activated in different T-cell subtypes (CD4 + and CD8 + T cells) at different stages of infection remain unclear. We obtained transcriptome data of five individuals each with early HIV infection, chronic progressive HIV infection, and no HIV infection. Weighted gene co-expression network analysis was used to evaluate changes in gene expression to determine the antiviral response. An advanced metabolic algorithm was then applied to compare the alterations in metabolic pathways in the two T-cell subtypes at different infection stages. We identified 23 and 20 co-expressed gene modules in CD4 + T and CD8 + T cells, respectively. CD4 + T cells from individuals in the early HIV infection stage were enriched in genes involved in metabolic and infection-related pathways, whereas CD8 + T cells were enriched in genes involved in cell cycle and DNA replication. Three key modules were identified in the network common to the two cell types: NLRP1 modules , RIPK1 modules, and RIPK2 modules. The specific role of NLRP1 in the regulation of HIV infection in the human body remains to be determined. Metabolic functional analysis of the two cells showed that the significantly altered metabolic pathways after HIV infection were valine, leucine, and isoleucine degradation; beta-alanine metabolism; and PPAR signaling pathways. In summary, we found the core gene expression modules and different pathways activated in CD4 + and CD8 + T cells, along with changes in their metabolic pathways during HIV infection progression. These findings can provide an overall resource for establishing biomarkers to facilitate early diagnosis and potential guidance for new targeted therapeutic strategies.

genetics & heredity
Multi-Omics Single-Cell Analysis Reveals Key Regulators of HIV-1 Persistence and Aberrant Host Immune Responses in Early Infection

Dayeon Lee,Sin Young Choi,So-I Shin,Hyunsu An,Byeong-Sun Choi,Jihwan Park

DOI: https://doi.org/10.1101/2024.11.04.621999

2024-11-05

Abstract:The clearance of human immunodeficiency virus-1 (HIV-1) remains a significant public health challenge due to impaired cellular immune responses and HIV-1 maintenance during acute infection. However, the genetic and epigenetic changes influencing the immune response on host infected cells remain unclear. Here, this study analyzes HIV-1 infected CD4+ T cells from peripheral blood mononuclear cells from people living with HIV-1 (PLWH) during early infection (<6 months) using single-cell RNA and ATAC sequencing. It is observed that HIV-1 hinders the antiviral response, particularly by interfering with the interferon signalling pathway. Multimodal analysis identifies KLF2 as a key transcription factor in infected CD4+ T cells. Moreover, cells harbouring HIV-1 provirus are predominantly identified as Th17 cells, which exhibit elevated KLF2 activity. This suggests an increased susceptibility to HIV-1 infection and a constrained immune response due to the quiescent characteristics of these cells. The finding provides insights into the immune mechanisms and key regulators of HIV-1 maintenance in CD4+ T cells during the early stages of infection.

Microbiology
Mitochondrial Functions Are Compromised in CD4 T Cells From ART-Controlled PLHIV

Juan Zhao,Madison Schank,Ling Wang,Zhengke Li,Lam Nhat Nguyen,Xindi Dang,Dechao Cao,Sushant Khanal,Lam Ngoc Thao Nguyen,Bal Krishna Chand Thakuri,Stella C. Ogbu,Zeyuan Lu,Xiao Y. Wu,Zheng D. Morrison,Mohamed El Gazzar,Ying Liu,Jinyu Zhang,Shunbin Ning,Jonathan P. Moorman,Zhi Q. Yao

DOI: https://doi.org/10.3389/fimmu.2021.658420

IF: 7.3

2021-05-04

Frontiers in Immunology

Abstract:The hallmark of HIV/AIDS is a gradual depletion of CD4 T cells. Despite effective control by antiretroviral therapy (ART), a significant subgroup of people living with HIV (PLHIV) fails to achieve complete immune reconstitution, deemed as immune non-responders (INRs). The mechanisms underlying incomplete CD4 T cell recovery in PLHIV remain unclear. In this study, CD4 T cells from PLHIV were phenotyped and functionally characterized, focusing on their mitochondrial functions. The results show that while total CD4 T cells are diminished, cycling cells are expanded in PLHIV, especially in INRs. HIV-INR CD4 T cells are more activated, displaying exhausted and senescent phenotypes with compromised mitochondrial functions. Transcriptional profiling and flow cytometry analysis showed remarkable repression of mitochondrial transcription factor A (mtTFA) in CD4 T cells from PLHIV, leading to abnormal mitochondrial and T cell homeostasis. These results demonstrate a sequential cellular paradigm of T cell over-activation, proliferation, exhaustion, senescence, apoptosis, and depletion, which correlates with compromised mitochondrial functions. Therefore, reconstituting the mtTFA pathway may provide an adjunctive immunological approach to revitalizing CD4 T cells in ART-treated PLHIV, especially in INRs.

immunology
Inverted CD8 T-Cell Exhaustion and Co-Stimulation Marker Balance Differentiate Aviremic HIV-2-Infected From Seronegative Individuals

Lydia Scharf,Christina B. Pedersen,Emil Johansson,Jacob Lindman,Lars R. Olsen,Marcus Buggert,Sten Wilhelmson,Fredrik Månsson,Joakim Esbjörnsson,Antonio Biague,Patrik Medstrand,Hans Norrgren,Annika C. Karlsson,Marianne Jansson,the SWEGUB CORE Group,Lars R. Olsen,

DOI: https://doi.org/10.3389/fimmu.2021.744530

IF: 7.3

2021-10-12

Frontiers in Immunology

Abstract:HIV-2 is less pathogenic compared to HIV-1. Still, disease progression may develop in aviremic HIV-2 infection, but the driving forces and mechanisms behind such development are unclear. Here, we aimed to reveal the immunophenotypic pattern associated with CD8 T-cell pathology in HIV-2 infection, in relation to viremia and markers of disease progression. The relationships between pathological differences of the CD8 T-cell memory population and viremia were analyzed in blood samples obtained from an occupational cohort in Guinea-Bissau, including HIV-2 viremic and aviremic individuals. For comparison, samples from HIV-1- or dually HIV-1/2-infected and seronegative individuals were obtained from the same cohort. CD8 T-cell exhaustion was evaluated by the combined expression patterns of activation, stimulatory and inhibitory immune checkpoint markers analyzed using multicolor flow cytometry and advanced bioinformatics. Unsupervised multidimensional clustering analysis identified a cluster of late differentiated CD8 T-cells expressing activation (CD38+, HLA-DR int/high ), co-stimulatory (CD226+/-), and immune inhibitory (2B4+, PD-1 high , TIGIT high ) markers that distinguished aviremic from viremic HIV-2, and treated from untreated HIV-1-infected individuals. This CD8 T-cell population displayed close correlations to CD4%, viremia, and plasma levels of IP-10, sCD14 and beta-2 microglobulin in HIV-2 infection. Detailed analysis revealed that aviremic HIV-2-infected individuals had higher frequencies of exhausted TIGIT+ CD8 T-cell populations lacking CD226, while reduced percentage of stimulation-receptive TIGIT-CD226+ CD8 T-cells, compared to seronegative individuals. Our results suggest that HIV-2 infection, independent of viremia, skews CD8 T-cells towards exhaustion and reduced co-stimulation readiness. Further knowledge on CD8 T-cell phenotypes might provide help in therapy monitoring and identification of immunotherapy targets.

immunology
Reversal of the CD8+ T-Cell Exhaustion Induced by Chronic HIV-1 Infection Through Combined Blockade of the Adenosine and PD-1 Pathways

Jing Li,Hui-Huang Huang,Bo Tu,Ming-Ju Zhou,Wei Hu,Yu-Long Fu,Xiao-Yu Li,Tao Yang,Jin-Wen Song,Xing Fan,Yan-Mei Jiao,Ruo-Nan Xu,Ji-Yuan Zhang,Chun-Bao Zhou,Jin-Hong Yuan,Cheng Zhen,Ming Shi,Fu-Sheng Wang,Chao Zhang

DOI: https://doi.org/10.3389/fimmu.2021.687296

IF: 7.3

2021-06-10

Frontiers in Immunology

Abstract:Background Targeting immune checkpoints for HIV treatment potentially provides a double benefit resulting from the ability to restore viral-specific CD8 + T-cell functions and enhance HIV production from reservoir cells. Despite promising pre-clinical data, PD-1 blockade alone in HIV-1-infected patients with advanced cancer has shown limited benefits in controlling HIV, suggesting the need for additional targets beyond PD-1. CD39 and PD-1 are highly co-expressed on CD8 + T cells in HIV-1 infection. However, the characteristics of CD39 and PD-1 dual-positive CD8 + T-cell subsets in chronic HIV-1 infection remain poorly understood. Methods This study enrolled 72 HIV-1-infected patients, including 40 treatment naïve and 32 ART patients. A total of 11 healthy individuals were included as controls. Different subsets of CD8 + T cells defined by CD39 and/or PD-1 expression were studied by flow cytometry. The relationships between the frequencies of the different subsets and parameters indicating HIV-1 disease progression were analyzed. Functional (i.e., cytokine secretion, viral inhibition) assays were performed to evaluate the impact of the blockade of adenosine and/or PD-1 signaling on CD8 + T cells. Results The proportions of PD-1 + , CD39 + , and PD-1 + CD39 + CD8 + T cells were significantly increased in treatment naïve patients but were partially lowered in patients on antiretroviral therapy. In treatment naïve patients, the proportions of PD-1 + CD39 + CD8 + T cells were negatively correlated with CD4 + T-cell counts and the CD4/CD8 ratio, and were positively correlated with viral load. CD39 + CD8 + T cells expressed high levels of the A2A adenosine receptor and were more sensitive to 2-chloroadenosine-mediated functional inhibition than their CD39 - counterparts. In vitro , a combination of blocking CD39/adenosine and PD-1 signaling showed a synergic effect in restoring CD8 + T-cell function, as evidenced by enhanced abilities to secrete functional cytokines and to kill autologous reservoir cells. Conclusion In patients with chronic HIV-1 infection there are increased frequencies of PD-1 + , CD39 + , and PD-1 + CD39 + CD8 + T cells. In treatment naïve patients, the frequencies of PD-1 + CD39 + CD8 + T cells are negatively correlated with CD4 + T-cell counts and the CD4/CD8 ratio and positively correlated with viral load. Combined blockade of CD39/adenosine and PD-1 signaling in vitro may exert a synergistic effect in restoring CD8 + T-cell function in HIV-1-infected patients.

immunology
Altered memory CCR6+ Th17-polarised T-cell function and biology in people with HIV under successful antiretroviral therapy and HIV elite controllers

Alexis Yero,Jean-Philippe Goulet,Tao Shi,Cecilia T Costiniuk,Jean-Pierre Routy,Cecile Tremblay,Ralph-Sydney Mboumba Bouassa,Yulia Alexandrova,Amélie Pagliuzza,Nicolas Chomont,Petronela Ancuta,Mohammad-Ali Jenabian

DOI: https://doi.org/10.1016/j.ebiom.2024.105274

IF: 11.205

2024-08-22

EBioMedicine

Abstract:Background: Despite successful antiretroviral therapy (ART), frequencies and immunological functions of memory CCR6+ Th17-polarised CD4+ T-cells are not fully restored in people with HIV (PWH). Moreover, long-lived Th17 cells contribute to HIV persistence under ART. However, the molecular mechanisms underlying these observations remain understudied. Methods: mRNA-sequencing was performed using Illumina technology on freshly FACS-sorted memory CCR6+CD4+ T-cells from successfully ART-treated (ST), elite controllers (EC), and uninfected donors (HD). Gene expression validation was performed by RT-PCR, flow cytometry, and in vitro functional assays. Findings: Decreased Th17 cell frequencies in STs and ECs versus HDs coincided with reduced Th17-lineage cytokine production in vitro. Accordingly, the RORγt/RORC2 repressor NR1D1 was upregulated, while the RORγt/RORC2 inducer Semaphorin 4D was decreased in memory CCR6+ T-cells of STs and ECs versus HDs. The presence of HIV-DNA in memory CCR6+ T-cells of ST and EC corresponded with the downregulation of HIV restriction factors (SERINC3, KLF3, and RNF125) and HIV inhibitors (tetraspanins), along with increased expression of the HIV-dependency factor MRE11, indicative of higher susceptibility/permissiveness to HIV-1 infection. Furthermore, markers of DNA damage/modification were elevated in memory CCR6+ T-cells of STs and ECs versus HDs, in line with their increased activation (CD38/HLA-DR), senescence/exhaustion phenotype (CTLA-4/PD-1/CD57) and their decreased expression of proliferation marker Ki-67. Interpretation: These results reveal new molecular mechanisms of Th17 cell deficit in ST and EC PWH despite a successful control of HIV-1 replication. This knowledge points to potential therapeutic interventions to limit HIV-1 infection and restore frequencies, effector functions, and senescence/exhaustion in Th17 cells. Funding: This study was funded by the Canadian Institutes of Health Research (CIHR, operating grant MOP 142294, and the Canadian HIV Cure Enterprise [CanCURE 2.0] Team Grant HB2 164064), and in part, by the Réseau SIDA et maladies infectieuses du Fonds de recherche du Québec-Santé (FRQ-S).
Mechanisms of residual immune activation in HIV-1-infected human lymphoid tissue ex vivo

Vincenzo Mercurio,Wendy Fitzgerald,Christophe Vanpouille,Ivan Molodtsov,Leonid Margolis

DOI: https://doi.org/10.1097/QAD.0000000000002881

IF: 4.632

2021-07-01

AIDS

Abstract:Objective: HIV-1 infection triggers immune activation, as reflected by the upregulation of various cytokines. This immune activation remains elevated despite antiretroviral therapy (ART) and leads to early age-related diseases. Here, we addressed the mechanisms of sustained immune activation in HIV-1-infected human lymphoid tissues ex vivo. Design/method: We investigated several potential causes of immunoactivation, including: a proinflammatory effect of ART drugs themselves; an early HIV-1-triggered cytokine storm, which could in turn trigger a sustained cytokine dysregulation; herpesvirus reactivation; HIV-1 protein release; and production of defective virions and extracellular vesicles. Tissue immune activation was evaluated from measurements of cytokines in culture medium using multiplexed immunoassays. Results: Neither ART itself nor simulated cytokine storms nor exogenously added HIV-1 proteins triggered a sustained cytokine upregulation. In contrast, defective (replicative-incompetent) virions and extracellular vesicles induced sustained cytokine upregulation, as did infectious virus. Tissue immune activation was accompanied by reactivation of cytomegalovirus. Conclusion: The system of ex-vivo human lymphoid tissue allowed investigation, under laboratory-controlled conditions, of possible mechanisms involved in persistent immune activation in HIV-1 patients under ART. Mechanisms of this immunoactivation identified in ex-vivo tissues may indicate potential therapeutic targets for restoration of immune system homeostasis in HIV-1-infected patients.
Clonal succession after prolonged antiretroviral therapy rejuvenates CD8 + T cell responses against HIV-1

Eoghann White,Laura Papagno,Assia Samri,Kenji Sugata,Boris Hejblum,Amy R. Henry,Daniel C. Rogan,Samuel Darko,Patricia Recordon-Pinson,Yasmine Dudoit,Sian Llewellyn-Lacey,Lisa A. Chakrabarti,Florence Buseyne,Stephen A. Migueles,David A. Price,Marie-Aline Andreola,Yorifumi Satou,Rodolphe Thiebaut,Christine Katlama,Brigitte Autran,Daniel C. Douek,Victor Appay

DOI: https://doi.org/10.1038/s41590-024-01931-9

IF: 30.5

2024-08-25

Nature Immunology

Abstract:Human immunodeficiency virus 1 (HIV-1) infection is characterized by a dynamic and persistent state of viral replication that overwhelms the host immune system in the absence of antiretroviral therapy (ART). The impact of prolonged treatment on the antiviral efficacy of HIV-1-specific CD8 + T cells has nonetheless remained unknown. Here, we used single-cell technologies to address this issue in a cohort of aging individuals infected early during the pandemic and subsequently treated with continuous ART. Our data showed that long-term ART was associated with a process of clonal succession, which effectively rejuvenated HIV-1-specific CD8 + T cell populations in the face of immune senescence. Tracking individual transcriptomes further revealed that initially dominant CD8 + T cell clonotypes displayed signatures of exhaustion and terminal differentiation, whereas newly dominant CD8 + T cell clonotypes displayed signatures of early differentiation and stemness associated with natural control of viral replication. These findings reveal a degree of immune resilience that could inform adjunctive treatments for HIV-1.

immunology
Examining Chronic Inflammation, Immune Metabolism, and T Cell Dysfunction in HIV Infection

Wenli Mu,Vaibhavi Patankar,Scott Kitchen,Anjie Zhen

DOI: https://doi.org/10.3390/v16020219

2024-02-01

Viruses

Abstract:Chronic Human Immunodeficiency Virus (HIV) infection remains a significant challenge to global public health. Despite advances in antiretroviral therapy (ART), which has transformed HIV infection from a fatal disease into a manageable chronic condition, a definitive cure remains elusive. One of the key features of HIV infection is chronic immune activation and inflammation, which are strongly associated with, and predictive of, HIV disease progression, even in patients successfully treated with suppressive ART. Chronic inflammation is characterized by persistent inflammation, immune cell metabolic dysregulation, and cellular exhaustion and dysfunction. This review aims to summarize current knowledge of the interplay between chronic inflammation, immune metabolism, and T cell dysfunction in HIV infection, and also discusses the use of humanized mice models to study HIV immune pathogenesis and develop novel therapeutic strategies.

virology

[Treatment of cardiogenic shock in acute coronary syndrome. Do logistics follow logic?].

Telomerase Activity of Hiv-1-Specific Cd8(+) T Cells: Constitutive Up-Regulation in Controllers and Selective Increase by Blockade of Pd Ligand 1 in Progressors

Altered differentiation is central to HIV-specific CD4+ T cell dysfunction in progressive disease

Persistent T Cell Repertoire Perturbation and T Cell Activation in HIV After Long Term Treatment

[The effect of local injection of interferon against human malignant glioma transplanted into nude mice and the mechanism of its effect].

Seeking "protective" and "harmful" immune genes during chronic HIV-1 infection by transcriptome analysis

Metabolic and mitochondrial dysregulation in CD4+ T cells from HIV-positive women on combination anti-retroviral therapy

Genome-wide analysis of primary CD4+ and CD8+ T cell transcriptomes shows evidence for a network of enriched pathways associated with HIV disease

Reversible Reprogramming of Circulating Memory T Follicular Helper Cell Function during Chronic HIV Infection

Human heterophile antibodies recognizing epitopes present on insect glycolipids.

Distinct Mitochondrial Disturbance in CD4+T and CD8+T Cells From HIV-Infected Patients

Metabolic reprogramming of immune cells in HIV infection and treatment

Landscape of T Cells Transcriptional and Metabolic Modules During HIV Infection Based on Weighted Gene Co-expression Network Analysis

Multi-Omics Single-Cell Analysis Reveals Key Regulators of HIV-1 Persistence and Aberrant Host Immune Responses in Early Infection

Mitochondrial Functions Are Compromised in CD4 T Cells From ART-Controlled PLHIV

Inverted CD8 T-Cell Exhaustion and Co-Stimulation Marker Balance Differentiate Aviremic HIV-2-Infected From Seronegative Individuals

Reversal of the CD8+ T-Cell Exhaustion Induced by Chronic HIV-1 Infection Through Combined Blockade of the Adenosine and PD-1 Pathways

Altered memory CCR6+ Th17-polarised T-cell function and biology in people with HIV under successful antiretroviral therapy and HIV elite controllers

Mechanisms of residual immune activation in HIV-1-infected human lymphoid tissue ex vivo

Clonal succession after prolonged antiretroviral therapy rejuvenates CD8 + T cell responses against HIV-1

Examining Chronic Inflammation, Immune Metabolism, and T Cell Dysfunction in HIV Infection